Benign Prostate Hyperplasia
3 competing products in clinical development for Benign Prostate Hyperplasia.
Pipeline by Phase
Phase 21
Phase 31
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| 5 mg Tadalafil + Placebo + 0.2 mg Tamsulosin | Eli Lilly | Phase 3 | Completed | 40 |
| Tamsulosin + Finasteride + Placebo | Astellas Pharma | Approved | UNKNOWN | 39 |
| ASP4901 + Tamsulosin + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |